INFINITY PHARMACEUTICALS INC (INFI)
US45665G3039 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 17.75M | 38.31M | 80.73M | 28.60M | 22.30M | |||
| Marketable Securities | N/A | N/A | 0.00 | 5.50M | 20.20M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 2.16M | 1.99M | 1.54M | 1.90M | 2.20M | |||
| Total Current Assets | 19.91M | 40.30M | 82.27M | 36.00M | 44.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.08M | 1.50M | 2.31M | 3.10M | 3.90M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 242.00K | 352.00K | 212.00K | 200.00K | 500.00K | |||
| Total Non-Current Assets | 1.32M | 1.85M | 2.52M | 3.30M | 4.40M | |||
| TOTAL ASSETS | 21.23M | 42.15M | 84.78M | 39.30M | 49.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 10.56M | 9.22M | 10.98M | 8.10M | 8.10M | |||
| Accounts Payable | 1.50M | 4.41M | 2.32M | 3.00M | 1.60M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 12.06M | 13.63M | 13.30M | 11.00M | 9.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 46.57M | 47.57M | 49.91M | 51.30M | 31.60M | |||
| Total Non-Current Liabilities | 46.57M | 47.57M | 49.91M | 51.30M | 31.60M | |||
| TOTAL LIABILITIES | 58.64M | 61.20M | 63.21M | 62.30M | 41.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -876.95M | -855.95M | -811.58M | -766.30M | -725.80M | |||
| Additional Paid In Capital | 839.46M | 836.81M | 833.07M | 743.30M | 733.50M | |||
| Common Shares | 90.00K | 89.00K | 89.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 90.76M | 89.41M | 89.16M | 64.30M | 57.10M | |||
| Tangible Book Value per Share | -0.41 | -0.21 | 0.24 | -0.36 | 0.13 | |||
| Total Shareholders' Equity | -37.41M | -19.05M | 21.57M | -23.00M | 7.70M | |||
| TOTAL LIABILITIES AND EQUITY | 21.23M | 42.15M | 84.78M | 39.30M | 49.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.65 | 2.96 | 6.19 | 3.27 | 4.60 | |||
| Return On Assets (ROA) | -192.86% | -105.26% | -53.38% | -103.05% | -96.12% | |||
| Return On Equity (ROE) | N/A | N/A | -209.83% | N/A | -611.69% | |||
All data in USD